TABLE 4.
Clinical assessment related to peritoneal dialysis of study population for the last 3 months.
|
Total n = 123 |
CAPD n = 53 (43%) |
RM‐APD n = 40 (33%) |
APD n = 30 (24%) |
p value | |
|---|---|---|---|---|---|
| Constipation, n (%) | |||||
| Frequently (more than once per weak) | 16 (13) | 3 (6) | 10 (25) | 3 (10) | |
| PD solution discharge problem, n (%) | .3 | ||||
| No | 102 (83) | 46 (87) | 34 (85) | 22 (73) | |
| Frequently (more than once per month) | 21 (17) | 7 (13) | 6 (15) | 8 (27) | |
| How the problem was solved, n (%) | |||||
| Change position | 12 (57) | 3 (42) | 4 (66) | 5 (62) | |
| PD nurse call | 9 (43) | 4 (58) | 2 (33) | 3 (38) | |
| Add heparin to PD solution | 5 (23) | 2 (29) | 0 | 3 (38) | |
| Erythema at the PD catheter exit site, n (%) | .9 | ||||
| No | 108 (88) | 47 (89) | 35 (87) | 26 (87) | |
| Yes | 15 (12) | 6 (11) | 5 (13) | 4 (13) | |
| How the problem is solved, n (%) | |||||
| Daily care | 11 (69) | 5 (83) | 2 (40) | 4 (100) | |
| Topical antibiotic | 4 (31) | 1 (17) | 3 (60) | 0 | |
| Abdominal or groin hernia, n (%) | |||||
| Yes | 15 (12) | 4 (8) | 6 (15) | 5 (17) | .4 |
| Increase in size | 3 (20) | 1 (25) | 2 (33) | 0 | .3 |
| Cause to pain | 4 (27) | 1 (25) | 2 (33) | 1 (20) | .9 |
| Dialysis interruption, n (%) | |||||
| Frequently (more than once per month) | 10 (8) | 3 (6) | 2 (5) | 5 (17) | .04 |
| Why was the dialysis interrupted, n (%) | |||||
| Fatigue | 5 (50) | 1 (33) | 1 (50) | 3 (60) | |
| Not affect treatment adequacy | 5 (50) | 2 (66) | 1 (50) | 2 (40) | |
| Hospitalization, n (%) | |||||
| Peritonitis | 12 (10) | 6 (11) | 2 (5) | 4 (13) | .1 |
| COVID‐19 | 4 (3) | 2 (4) | 0 | 2 (6) | |
| CVD | 0 | 0 | 0 | 0 | |
| Others | 2 (2) | 2 (4) | 0 | 0 | |
| Hospitalization time | 6 (5) | 2 (4) | 2 (5) | 2 (6) | |
Abbreviations: APD, automatized peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; PD, peritoneal dialysis; COVID‐19, novel coronavirus disease; RM‐APD, remote monitoring automatized peritoneal dialysis.